Skip to content

Drug interactions

Bedaquiline + Octreotide

Severity: Moderate

Bedaquiline and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QTc interval, so using them together may increase the risk of torsades de pointes. Octreotide is also associated with bradycardia, which can add to arrhythmic risk. The risk is greater with electrolyte disturbances or underlying cardiac disease.

What this interaction means in plain words

Bedaquiline and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bedaquiline belongs to Anti Bacterial; Octreotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Obtain a baseline ECG and repeat during therapy, and correct potassium, magnesium and calcium abnormalities. Stop or reassess therapy if QTc becomes markedly prolonged or symptoms of arrhythmia appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bedaquiline and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bedaquiline with Octreotide?

MediHelp rates the interaction as moderate. Bedaquiline and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QTc interval, so using them together may increase the risk of torsades de pointes. Octreotide is also associated with bradycardia, which can add to arrhythmic risk. The risk is greater with electrolyte disturbances or underlying cardiac disease.

How serious is the interaction between Bedaquiline and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and repeat during therapy, and correct potassium, magnesium and calcium abnormalities. Stop or reassess therapy if QTc becomes markedly prolonged or symptoms of arrhythmia appear.

What other medicines interact with Octreotide?

MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in